Does Rallies show 13F holders for SCNI?

Yes. Rallies tracks hedge fund and 13F ownership data for SCNI, including fund names, share counts, latest tracked quarter, and position changes when available.

Is SCNI research on Rallies investment advice?

No. Rallies provides research, data, and educational context for SCNI. It does not provide personalized investment advice.

SCNI (Scinai Immunotherapeutics Ltd. American Depositary Shares) Stock Analysis - Hedge Fund Holdings

Scinai Immunotherapeutics Ltd. American Depositary Shares (SCNI) is a publicly traded Healthcare sector company. As of May 20, 2026, SCNI trades at $0.48 with a market cap of $2.22M and a P/E ratio of 0.00. SCNI moved -3.56% today. Year to date, SCNI is -30.35%; over the trailing twelve months it is -81.98%. Its 52-week range spans $0.45 to $6.18. Rallies surfaces SCNI's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Who owns SCNI stock?

Hedge funds tracked by Rallies that own SCNI include Citadel Advisors. The latest tracked quarter is Mar 31, 2024. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Scinai Immunotherapeutics Ltd. American Depositary Shares.

SCNI Key Metrics

Key financial metrics for SCNI
Metric	Value
Price	$0.48
Market Cap	$2.22M
P/E Ratio	0.00
EPS	$0.00
Dividend Yield	0.00%
52-Week High	$6.18
52-Week Low	$0.45
Volume	792.02K
Avg Volume	0
Revenue (TTM)	$0
Net Income	$0
Gross Margin	0.00%

Top Hedge Funds Holding SCNI

Citadel Advisors holds 12.21K shares of SCNI, changed +0.00% as of Mar 31, 2024.

Latest SCNI News

Scinai Appoints Eilon Elmalem as Yavne CDMO Site Head Effective June 14, 2026 — May 20, 2026
Scinai Notified of Non-Compliance After ADS Drop Below $1 for 30 Days — Mar 16, 2026

Recent SCNI Insider Trades

BEATY ELWIN M bought 80.00K (~$5.20K) on Dec 14, 2007.
BEATY ELAINE E bought 80.00K (~$5.20K) on Dec 14, 2007.
BEATY ELWIN M sold 80.00K (~$5.20K) on Dec 14, 2007.

SCNI Analyst Consensus

SCNI analyst coverage data. Average price target: $0.00.

Common questions about SCNI

Who owns SCNI stock?: Hedge funds tracked by Rallies that own SCNI include Citadel Advisors. The latest tracked quarter is Mar 31, 2024. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Scinai Immunotherapeutics Ltd. American Depositary Shares.
Does Rallies show 13F holders for SCNI?: Yes. Rallies tracks hedge fund and 13F ownership data for SCNI, including fund names, share counts, latest tracked quarter, and position changes when available.
Is SCNI research on Rallies investment advice?: No. Rallies provides research, data, and educational context for SCNI. It does not provide personalized investment advice.